the PMHNP Podcast - Off-Label Use Medications episode artwork

EPISODE · Apr 5, 2025 · 1H 14M

the PMHNP Podcast - Off-Label Use Medications

from the PMHNP Podcast · host Dr. John Rossi

PMHNPtesting.com Podcast: Off-Label Psychopharm Mastery Hosted by Dr. John Rossi, DNP, PMHNP | Produced by Clarity Education Systems BONUS: Off-label use Quick Reference Guide now available in the Student Portal at www.PMHNPstudentportal.com! Welcome to the PMHNPtesting.com Podcast, where psychiatric mental health nurse practitioners (PMHNPs) dive deep into the cutting-edge world of psychopharmacology! We’re unlocking the power of off-label medication use—those evidence-backed, outside-the-box strategies that transform lives when standard treatments fall short. Whether you’re prepping for boards, sharpening your clinical edge, or just geeking out over psychopharm, this podcast is your go-to resource for mastering mental health care’s toughest challenges. Episode Spotlight: "Off-Label Meds for Mental Health – A Comprehensive Guide" Join us as we explore over 20 medications—spanning antidepressants, antipsychotics, mood stabilizers, anti-anxiety agents, anticonvulsants, stimulants, beta-blockers, and a wild-card miscellaneous crew—repurposed for mental health symptoms beyond their FDA-approved labels. From Trazodone’s sedative punch for insomnia to Ketamine’s rapid depression rescue, we’ve got the science, the practical know-how, and the pro tips to elevate your practice. What You’ll Learn: Evidence Base: Navigate the spectrum of support—from Ketamine’s robust 70% response rate in treatment-resistant depression (2020 NEJM) to Gabapentin’s anecdotal anxiety relief (2019 Journal of Anxiety Disorders). We break down clinical trials, meta-analyses, and expert consensus so you can weigh the strength behind each off-label use. Mechanisms of Action: Get under the hood—e.g., how Quetiapine’s H1 blockade sedates insomnia, Lithium’s inositol inhibition curbs suicidal ideation, or Naltrexone’s mu-opioid blockade rewires binge eating urges. Off-Label Applications: Discover versatile uses—like Propranolol for performance anxiety, Methylphenidate for cancer fatigue, or Lamotrigine for borderline personality disorder chaos—backed by studies like 2019 Pediatrics (Aripiprazole) and 2021 Addiction (Topiramate). Patient Care: Master dosing, titration, and patient counseling—e.g., start Prazosin at 1 mg for PTSD nightmares, warn about Topiramate’s “fog,” or taper Clonidine to dodge rebound hypertension. Monitoring: Stay ahead with lab checks (Lithium’s TSH), scales (OCD-YBOCS for Risperidone), and vitals (Pregabalin’s BMI)—ensuring safety and efficacy. Risks & Ethics: Tackle side effects (Olanzapine’s weight gain), efficacy gaps, and legal nuances with charting tips from Furey & Wilkins’ Prescribing “Off-Label”—e.g., document consent like “Patient agrees to Ketamine 0.5 mg/kg IV, risks (dissociation) discussed, per 2020 NEJM.” Episode Highlights: Antidepressants: Trazodone (insomnia), Bupropion (ADHD), Mirtazapine (appetite), Amitriptyline (pain). Antipsychotics: Quetiapine (GAD), Aripiprazole (OCD), Olanzapine (anorexia), Risperidone (PTSD). Mood Stabilizers: Lithium (suicide prevention), Lamotrigine (depression), Valproate (aggression). Anti-Anxiety: Buspirone (sexual dysfunction), Hydroxyzine (agitation). Anticonvulsants: Gabapentin (anxiety), Pregabalin (PTSD), Topiramate (binge eating). Stimulants: Methylphenidate (fatigue), Modafinil (MS fatigue). Beta-Blockers: Propranolol (performance anxiety). Miscellaneous: Clonidine (ADHD), Prazosin (nightmares), Ketamine (suicide), Naltrexone (self-injury), Memantine (OCD). Why Listen? This isn’t just a podcast—it’s a clinical toolkit. Each episode blends rigorous science (e.g., 2018 JAMA Psychiatry on Lithium’s 60% suicide risk reduction) with actionable insights (e.g., taper Valproate to avoid seizures). We wrap it up with ethical guidance—disclose off-label status, cite evidence, and chart like a pro—to keep you innovative yet covered. Perfect for PMHNPs aiming to ace exams, refine skills, or pioneer patient care. Tune In: Grab your coffee and stethoscope—join us at PMHNPtesting.com for a fun, functional, and fiercely practical psychopharm deep dive. Let’s transform mental health, one off-label script at a time! Disclaimer: This podcast is for educational purposes only. Consult a healthcare provider for clinical decisions.

PMHNPtesting.com Podcast: Off-Label Psychopharm Mastery Hosted by Dr. John Rossi, DNP, PMHNP | Produced by Clarity Education Systems BONUS: Off-label use Quick Reference Guide now available in the Student Portal at www.PMHNPstudentportal.com! Welcome to the PMHNPtesting.com Podcast, where psychiatric mental health nurse practitioners (PMHNPs) dive deep into the cutting-edge world of psychopharmacology! We’re unlocking the power of off-label medication use—those evidence-backed, outside-the-box strategies that transform lives when standard treatments fall short. Whether you’re prepping for boards, sharpening your clinical edge, or just geeking out over psychopharm, this podcast is your go-to resource for mastering mental health care’s toughest challenges. Episode Spotlight: "Off-Label Meds for Mental Health – A Comprehensive Guide" Join us as we explore over 20 medications—spanning antidepressants, antipsychotics, mood stabilizers, anti-anxiety agents, anticonvulsants, stimulants, beta-blockers, and a wild-card miscellaneous crew—repurposed for mental health symptoms beyond their FDA-approved labels. From Trazodone’s sedative punch for insomnia to Ketamine’s rapid depression rescue, we’ve got the science, the practical know-how, and the pro tips to elevate your practice. What You’ll Learn: Evidence Base: Navigate the spectrum of support—from Ketamine’s robust 70% response rate in treatment-resistant depression (2020 NEJM) to Gabapentin’s anecdotal anxiety relief (2019 Journal of Anxiety Disorders). We break down clinical trials, meta-analyses, and expert consensus so you can weigh the strength behind each off-label use. Mechanisms of Action: Get under the hood—e.g., how Quetiapine’s H1 blockade sedates insomnia, Lithium’s inositol inhibition curbs suicidal ideation, or Naltrexone’s mu-opioid blockade rewires binge eating urges. Off-Label Applications: Discover versatile uses—like Propranolol for performance anxiety, Methylphenidate for cancer fatigue, or Lamotrigine for borderline personality disorder chaos—backed by studies like 2019 Pediatrics (Aripiprazole) and 2021 Addiction (Topiramate). Patient Care: Master dosing, titration, and patient counseling—e.g., start Prazosin at 1 mg for PTSD nightmares, warn about Topiramate’s “fog,” or taper Clonidine to dodge rebound hypertension. Monitoring: Stay ahead with lab checks (Lithium’s TSH), scales (OCD-YBOCS for Risperidone), and vitals (Pregabalin’s BMI)—ensuring safety and efficacy. Risks & Ethics: Tackle side effects (Olanzapine’s weight gain), efficacy gaps, and legal nuances with charting tips from Furey & Wilkins’ Prescribing “Off-Label”—e.g., document consent like “Patient agrees to Ketamine 0.5 mg/kg IV, risks (dissociation) discussed, per 2020 NEJM.” Episode Highlights: Antidepressants: Trazodone (insomnia), Bupropion (ADHD), Mirtazapine (appetite), Amitriptyline (pain). Antipsychotics: Quetiapine (GAD), Aripiprazole (OCD), Olanzapine (anorexia), Risperidone (PTSD). Mood Stabilizers: Lithium (suicide prevention), Lamotrigine (depression), Valproate (aggression). Anti-Anxiety: Buspirone (sexual dysfunction), Hydroxyzine (agitation). Anticonvulsants: Gabapentin (anxiety), Pregabalin (PTSD), Topiramate (binge eating). Stimulants: Methylphenidate (fatigue), Modafinil (MS fatigue). Beta-Blockers: Propranolol (performance anxiety). Miscellaneous: Clonidine (ADHD), Prazosin (nightmares), Ketamine (suicide), Naltrexone (self-injury), Memantine (OCD). Why Listen?This isn’t just a podcast—it’s a clinical toolkit. Each episode blends rigorous science (e.g., 2018 JAMA Psychiatry on Lithium’s 60% suicide risk reduction) with actionable insights (e.g., taper Valproate to avoid seizures). We wrap it up with ethical guidance—disclose off-label status, cite evidence, and chart like a pro—to keep you innovative yet covered. Perfect for PMHNPs aiming to ace exams, refine skills, or pioneer patient care. Tune In:Grab your coffee and stethoscope—join us at PMHNPtestin

NOW PLAYING

the PMHNP Podcast - Off-Label Use Medications

0:00 1:14:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of the PMHNP Podcast?

This episode is 1 hour and 14 minutes long.

When was this the PMHNP Podcast episode published?

This episode was published on April 5, 2025.

What is this episode about?

PMHNPtesting.com Podcast: Off-Label Psychopharm Mastery Hosted by Dr. John Rossi, DNP, PMHNP | Produced by Clarity Education Systems BONUS: Off-label use Quick Reference Guide now available in the Student Portal at...

Can I download this the PMHNP Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!